Rapid Communication - Journal of Clinical Respiratory Medicine (2025) Volume 9, Issue 1
Respiratory Infections and Antibiotic Resistance: A Growing Clinical Challenge
Antonio Anzueto *
Pulmonary Diseases Section, University of Texas Health Science Center at San Antonio, USA
- *Corresponding Author:
- Antonio Anzueto
Pulmonary Diseases Section, University of Texas Health Science Center at San Antonio, USA
E-mail: anzuetoa@uthscsa.edu
Received: 1-Mar-2025, Manuscript No. aajcrm-25-167782; Editor assigned: 4-Mar-2025, PreQC No. aajcrm-25-167782 (PQ) Reviewed:17-Mar-2025, QC No. aajcrm-25-167782Revised:24-Mar-2025, Manuscript No. aajcrm-25-167782; Published:31-Mar-2025, DOI: 10.35841/ aajcrm - 9.1.250
Citation: Anzueto A. Respiratory infections and antibiotic resistance: A growing clinical challenge. J Clin Resp Med. 2025;9(1):250
Introduction
Respiratory infections, including pneumonia, bronchitis, and sinusitis, remain among the leading causes of morbidity and mortality worldwide. These infections, whether viral or bacterial, pose a significant public health burden, particularly in vulnerable populations such as the elderly, children, and those with compromised immune systems [1].
While antibiotics have traditionally played a crucial role in managing bacterial respiratory infections, the global rise in antibiotic resistance has emerged as a critical concern in effective treatment.The overuse and misuse of antibiotics—such as prescribing them for viral infections or not completing prescribed courses—have accelerated the emergence of resistant bacterial strains [2].
Pathogens like Streptococcus pneumoniae, Haemophilus influenzae, and Mycoplasma pneumoniae, which commonly cause respiratory infections, are increasingly exhibiting resistance to first-line antibiotics such as macrolides and beta-lactams [3].
Antibiotic resistance not only limits treatment options but also leads to prolonged illness, increased healthcare costs, and higher mortality rates. Moreover, multidrug-resistant organisms (MDROs) complicate clinical decision-making and require the use of more toxic or expensive alternatives [4].
Addressing this crisis requires a multifaceted approach, including the promotion of antibiotic stewardship programs, investment in the development of new antimicrobials, and public education on the appropriate use of antibiotics. Additionally, improved diagnostic tools to distinguish between bacterial and viral infections can reduce unnecessary antibiotic prescriptions [5].
Conclusion
Combating antibiotic resistance in respiratory infections demands urgent global collaboration. Without strategic action, the efficacy of current treatments may continue to decline, undermining decades of progress in infectious disease management.
References
- Guitor AK, Wright GD. Antimicrobial resistance and respiratory infections. Chest. 2018;154(5):1202-12.
- Klugman KP. Clinical impact of antibiotic resistance in respiratory tract infections. Int J Antimicrob Agents. 2007;29:S6-10.
- Church NA, McKillip JL. Antibiotic resistance crisis: Challenges and imperatives. Biologia. 2021;76(5):1535-50.
- Spach DH, Black D. Antibiotic resistance in community-acquired respiratory tract infections: Current issues. Ann Allergy Asthma Immunol. 1998;81(4):293-303.
- Dunbar LM. Current issues in the management of bacterial respiratory tract disease: The challenge of antibacterial resistance. Am J Med Sci. 2003;326(6):360-8.
Indexed at, Google Scholar, Cross Ref
Indexed at, Google Scholar, Cross Ref
Indexed at, Google Scholar, Cross Ref
Indexed at, Google Scholar, Cross Ref